Your browser doesn't support javascript.
loading
Evaluation of the risk of hypertension in patients treated with anti-CGRP monoclonal antibodies in a real-life study.
Guerzoni, Simona; Castro, Flavia Lo; Brovia, Daria; Baraldi, Carlo; Pani, Luca.
Afiliación
  • Guerzoni S; Digital and Predictive Medicine, Pharmacology and Clinical Metabolic Toxicology-Headache Center and Drug Abuse-Laboratory of Clinical Pharmacology and Pharmacogenomics; Department of Specialist Medicines, AOU Policlinico di Modena, Modena, Italy.
  • Castro FL; Digital and Predictive Medicine, Pharmacology and Clinical Metabolic Toxicology-Headache Center and Drug Abuse-Laboratory of Clinical Pharmacology and Pharmacogenomics; Department of Specialist Medicines, AOU Policlinico di Modena, Modena, Italy. locastroflavia@gmail.com.
  • Brovia D; Digital and Predictive Medicine, Pharmacology and Clinical Metabolic Toxicology-Headache Center and Drug Abuse-Laboratory of Clinical Pharmacology and Pharmacogenomics; Department of Specialist Medicines, AOU Policlinico di Modena, Modena, Italy.
  • Baraldi C; Pharmacology Unit; Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.
  • Pani L; Digital and Predictive Medicine, Pharmacology and Clinical Metabolic Toxicology-Headache Center and Drug Abuse-Laboratory of Clinical Pharmacology and Pharmacogenomics; Department of Specialist Medicines, AOU Policlinico di Modena, Modena, Italy.
Neurol Sci ; 45(4): 1661-1668, 2024 Apr.
Article en En | MEDLINE | ID: mdl-37926748

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Hipertensión / Anticuerpos Monoclonales Límite: Humans Idioma: En Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Hipertensión / Anticuerpos Monoclonales Límite: Humans Idioma: En Año: 2024 Tipo del documento: Article